Article Details
Retrieved on: 2018-04-29 20:00:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>New investor OrbiMed led the $63 million Synthorx financing, joined by Medicxi and Osage University Partners, and existing investors, <b>Avalon Ventures</b>, RA Capital Management, and Correlation Ventures. It's a small amount compared to the investments of pharmaceutical companies. These include a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here